Cargando…

Combining behavioral weight loss treatment and a commercial program: A randomized clinical trial

Commercial weight loss programs such as Weight Watchers (WW) offer widely recognized and accessible treatment, but typically produce weight losses that are modest relative to professionally delivered programs. This study tested the hypothesis that a novel weight loss approach that combined the funda...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Angela Marinilli, Fava, Joseph L., Hoffmann, Debra A., Wing, Rena R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657569/
https://www.ncbi.nlm.nih.gov/pubmed/23404824
http://dx.doi.org/10.1002/oby.20044
_version_ 1782270148934107136
author Pinto, Angela Marinilli
Fava, Joseph L.
Hoffmann, Debra A.
Wing, Rena R.
author_facet Pinto, Angela Marinilli
Fava, Joseph L.
Hoffmann, Debra A.
Wing, Rena R.
author_sort Pinto, Angela Marinilli
collection PubMed
description Commercial weight loss programs such as Weight Watchers (WW) offer widely recognized and accessible treatment, but typically produce weight losses that are modest relative to professionally delivered programs. This study tested the hypothesis that a novel weight loss approach that combined the fundamental components of professionally delivered behavioral weight loss (BWL) treatment with the existing WW program would produce better weight losses than WW alone; no differences were expected between the novel treatment and BWL alone. Participants were 141 overweight and obese adults (90% women, 67% non-White, mean age = 49.7 ± 9.2 years, mean BMI = 36.2 ± 5.5 kg/m(2)) randomly assigned to 48 weeks of BWL, 48 weeks of WW, or 12 weeks of BWL followed by 36 weeks of WW (Combined Treatment, CT). Assessments were conducted at baseline and weeks 12, 24, and 48, with weight change as the primary outcome. Linear mixed model analysis showed that 24-week weight losses did not differ significantly between treatment groups; however, weight losses at 48 weeks were greater in the WW group (M=6.0 kg, SE=0.8) compared to the CT group (M=3.6 kg, SE=0.8; p=0.032), with BWL not significantly different from either (M=5.4 kg, SE=0.8). Further, a greater proportion of WW participants lost 10% of baseline weight by 48 weeks compared to BWL or CT (36.7%, 13.0%, and 15.2%, respectively, p’s<0.05). This study shows that the WW program can produce clinically meaningful weight losses and provides no evidence that adding brief BWL to the WW program improves outcome.
format Online
Article
Text
id pubmed-3657569
institution National Center for Biotechnology Information
language English
publishDate 2013
record_format MEDLINE/PubMed
spelling pubmed-36575692013-10-01 Combining behavioral weight loss treatment and a commercial program: A randomized clinical trial Pinto, Angela Marinilli Fava, Joseph L. Hoffmann, Debra A. Wing, Rena R. Obesity (Silver Spring) Article Commercial weight loss programs such as Weight Watchers (WW) offer widely recognized and accessible treatment, but typically produce weight losses that are modest relative to professionally delivered programs. This study tested the hypothesis that a novel weight loss approach that combined the fundamental components of professionally delivered behavioral weight loss (BWL) treatment with the existing WW program would produce better weight losses than WW alone; no differences were expected between the novel treatment and BWL alone. Participants were 141 overweight and obese adults (90% women, 67% non-White, mean age = 49.7 ± 9.2 years, mean BMI = 36.2 ± 5.5 kg/m(2)) randomly assigned to 48 weeks of BWL, 48 weeks of WW, or 12 weeks of BWL followed by 36 weeks of WW (Combined Treatment, CT). Assessments were conducted at baseline and weeks 12, 24, and 48, with weight change as the primary outcome. Linear mixed model analysis showed that 24-week weight losses did not differ significantly between treatment groups; however, weight losses at 48 weeks were greater in the WW group (M=6.0 kg, SE=0.8) compared to the CT group (M=3.6 kg, SE=0.8; p=0.032), with BWL not significantly different from either (M=5.4 kg, SE=0.8). Further, a greater proportion of WW participants lost 10% of baseline weight by 48 weeks compared to BWL or CT (36.7%, 13.0%, and 15.2%, respectively, p’s<0.05). This study shows that the WW program can produce clinically meaningful weight losses and provides no evidence that adding brief BWL to the WW program improves outcome. 2013-04 /pmc/articles/PMC3657569/ /pubmed/23404824 http://dx.doi.org/10.1002/oby.20044 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Pinto, Angela Marinilli
Fava, Joseph L.
Hoffmann, Debra A.
Wing, Rena R.
Combining behavioral weight loss treatment and a commercial program: A randomized clinical trial
title Combining behavioral weight loss treatment and a commercial program: A randomized clinical trial
title_full Combining behavioral weight loss treatment and a commercial program: A randomized clinical trial
title_fullStr Combining behavioral weight loss treatment and a commercial program: A randomized clinical trial
title_full_unstemmed Combining behavioral weight loss treatment and a commercial program: A randomized clinical trial
title_short Combining behavioral weight loss treatment and a commercial program: A randomized clinical trial
title_sort combining behavioral weight loss treatment and a commercial program: a randomized clinical trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657569/
https://www.ncbi.nlm.nih.gov/pubmed/23404824
http://dx.doi.org/10.1002/oby.20044
work_keys_str_mv AT pintoangelamarinilli combiningbehavioralweightlosstreatmentandacommercialprogramarandomizedclinicaltrial
AT favajosephl combiningbehavioralweightlosstreatmentandacommercialprogramarandomizedclinicaltrial
AT hoffmanndebraa combiningbehavioralweightlosstreatmentandacommercialprogramarandomizedclinicaltrial
AT wingrenar combiningbehavioralweightlosstreatmentandacommercialprogramarandomizedclinicaltrial